Table 2.
Patient No | Cause of death | Survival after PBT (M) | Progression | Acute toxicity* | Late toxicity* |
---|---|---|---|---|---|
1 |
alive |
349 |
none |
none |
vertebral growth retardation, narrowed aorta |
2 |
alive |
61 |
none |
none |
none |
3 |
alive |
40 |
none |
none |
none |
4 |
alive |
39 |
none |
temporary hair loss, G1 pharyngitis |
None |
5 |
tumor |
9 |
bone |
G1 skin reaction |
None |
6 |
alive |
20 |
none |
None |
G1 skin pigmentation |
7 |
alive |
20 |
bone marrow |
None |
none |
8 |
alive |
18 |
none |
hair loss |
thin hair |
9 |
tumor |
11 |
brain |
G1 skin reaction |
none |
10 |
tumor |
11 |
bone |
none |
none |
11 |
tumor |
31 |
bone marrow |
none |
none |
12 |
tumor |
27 |
lymph node |
none |
none |
13 |
tumor |
5 |
liver |
none |
- |
14 | alive | 22 | none | none | none |
*G1: Grade 1 according to Criteria for Adverse Events version 3.0 of the National Cancer Institute and the late radiation morbidity scoring scheme of the Radiation Therapy Oncology Study Group/European Organization for Research and Treatment of Cancer.